About Index Trending news
Analyze
Top 50 Pricing
Cerulean Pharma, Inc

Cerulean Pharma, Inc

Work at Cerulean Pharma, Inc? Add yourself to this profile

Cerulean Pharma, Inc

Cerulean Pharma develops nanotechnology-based therapeutics for treating oncology, cardiovascular, autoimmune and inflammatory diseases.

Elsewhere

Alexa global traffic share

Latest funding Show all
Post-IPO equity
$35,000,000
Debt financing
$26,000,000
Employees

Team size

10+
Locations
HQ
Xconomy

Cerulean's Shares Routed as Cancer Drug Comes up Short Again